Cancer cells with a long breath: seeking the origin of brain tumors in children

August 13, 2008

Medulloblastoma is one of the most common and most malignant brain tumours among children and teenagers. These tumours grow very rapidly, and fifty percent of patients in the long term die from the condition. The details of the processes that lead to the growth of these tumours have remained unknown until now. In two studies, working together with international scientific teams, LMU medical scientist Dr. Ulrich Schüller has now successfully revealed certain molecular mechanisms that lead to the development of these cerebellar tumours. As reported in the current issue of the journal Cancer Cell, the researchers triggered genetic changes in cell populations in the brains of mice in order to provoke the growth of tumours. It turned out that medulloblastomas arose from only one type of cell - granule cells - and only if these were already fully committed. "Medulloblastomas are presently treated with nonspecific methods," states Schüller. "Our results could contribute to the development of targeted therapies, and thus improve the treatment of cerebellar tumours in children."

When children develop cancer, about every fifth tumour is a brain tumour - and every fifth of those in turn is a medulloblastoma. This common tumour occurs most of all in children under ten years of age, but also occurs in adults, albeit very infrequently. Up to now, medulloblastomas have only been treatable with the standard tools of cancer medicine: operation, radiotherapy and chemotherapy. Surgical interventions to treat this condition, like all operations on the brain, are particularly delicate, since it is difficult to remove the tumour completely without affecting healthy tissue. Because these cerebellar tumours scatter easily throughout the brain and even in the medullary canal, many cases result in metastases, that is the growth of secondary tumours, and not infrequently to a relapse of the original tumour - often even after successful conclusion of the treatment.

That is why patients and doctors are hoping for more targeted therapies that promise better therapeutic outcomes. "But for that to be possible, we first need to understand the principles of how the tumours develop," says Schüller. "If we know how a tumour arises at the molecular level, we can also develop specific therapies that actually treat the cause of that particular condition." Since it was still unknown from what type of cell and at what stage of development medulloblastomas arise, the researchers induced specific genetic changes in various cell populations in the brains of mice. This "conditional knock-out" method provoked changes in the so-called sonic hedgehog signalling pathway. Various processes in the development of nerve cells are controlled by this molecular signalling cascade. "Normally, the signalling pathway ensures a balance of growth and maturation of cells," says Schüller. "But if disrupted, it can lead to uncontrolled growth of cells - and thus the onset of cancer".

In another step, the research team investigated the effects of mutations on nerve cells in various stages of development. Multipotent progenitor cells have the ability - almost like stem cells - to develop into many different types of cell, while "unipotent" progenitor cells can only develop into one specific type of cell. "All of our studies have shown that medulloblastomas can only develop from granule cells and their progenitors," Schüller tells us. "Other cells on the other hand, such as the large Purkinje cells of the cerebellum, do not become tumourigenic. They don't seem bothered by these mutations at all." And there is yet another distinctive result that the researchers achieved: the genetic changes only triggered one specific type of tumour: the medulloblastoma. Other brain tumours such as astrocytomas or oligodendrogliomas did not occur, even though, normally, the genetically attacked multipotent progenitors could have just as easily developed into astrocytes or oligodendrocytes.

It was especially surprising that even mutations in very early, immature cells triggered corresponding changes that only became tumourigenic if and when the cells had developed the characteristics of granule cells. The researchers were also surprised to find that the medulloblastomas appeared completely identical both morphologically and molecularly, no matter what stage of development they were triggered at. The researchers identified yet another factor in the development of medulloblastomas: the protein Olig2 has so far only been linked to the formation of glial cells in the brain, which primarily provide support for neurons. "But we also found Olig2 in progenitors of the granule cells of the cerebellum and in tumour cells," reports neuropathologist Schüller. "That means this protein also influences the formation and multiplication of cancer cells - which makes it clear once again just how closely normal and malignant development processes resemble one another. We hope our results will contribute to a targeted therapy for medulloblastomas. That will require further research, however, which we already have in the planning."

One of the funders of the studies was the German Cancer Aid, with whose assistance Schüller established one of two Max-Eder Young Investigator Groups at LMU.

Ludwig-Maximilians-Universität München

---

---

	Tumors of the Central Nervous System, Volume 8: Astrocytoma, Medulloblastoma, Retinoblastoma, Chordoma, Craniopharyngioma, Oligodendroglioma, and Ependymoma by M.A. Hayat (Editor) With tens of thousands of new CNS tumor cases each year in the US alone, this series of publications is a valuable aid to the diagnosis and treatment of these problematic neoplasms. Now, the eighth in the set returns to the topic of brain tumors, dealing with seven distinct types: astrocytoma, medulloblastoma, retinoblastoma, chordoma, craniopharyngioma, oligodendroglioma, and ependymoma. After updating the classification of medulloblastoma the volume provides an overview of ependymoma as well as describing the delineation of prognosis based on the genetic aberrations of the latter patients. The material offers key insights into the molecular pathways involved in tumor biology, such as the role of E-cadherin gene instability, carbonic anhydrase II, urokinase plasminogen activator, and Wnt...
	The Official Parent's Sourcebook on Childhood Medulloblastoma: A Revised and Updated Directory for the Internet Age by Icon Health Publications (Author) This sourcebook has been created for parents who have decided to make education and Internet-based research an integral part of the treatment process. Although it gives information useful to doctors, caregivers and other health professionals, it also tells parents where and how to look for information covering virtually all topics related to childhood medulloblastoma, from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on childhood medulloblastoma. Following an introductory chapter, the sourcebook...
	21st Century Pediatric Cancer Sourcebook: Brain and Spinal Cord Tumors - Neuroectodermal, Medulloblastoma, Glioma, Astrocytoma, Craniopharyngioma, Craniopharyngioma, CNS Tumors, Others by Progressive Management Authoritative information and practical advice from the nation's cancer experts about childhood brain and spinal cord tumors, including neuroectodermal tumors, medulloblastomas, gliomas, astrocytomas, craniopharyngiomas, craniopharyngiomas, CNS tumors, and others. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive compilation gives empowered patients, families, caregivers, nurses, and physicians the information they need to understand the diagnosis and treatment of this disease. In addition to disease-specific information, this ebook includes a glossary and information on the late effects of treatment for childhood cancer and pediatric supportive care. There are many types of childhood brain and spinal cord tumors....
	Gale Encyclopedia of Cancer: Medulloblastoma by D.O., M.P.H. Edward R. Rosick (Author) The article is excerpted from Gale Encyclopedia of Cancer The resource students and researchers will turn to for reliable, up-to-date and clearly written information, the Gale Encyclopedia of Cancer is a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures. The Encyclopedia includes entries covering cancers, cancer drugs, treatments, side effects and diagnostic procedures. Entries typically include the following elements: Causes and Symptoms Definition Description Diagnosis Prevention Resources Risks Special Concerns And more An appendix provides complete contact information for cancer centers, national support groups, government agencies and research groups. Features include anatomical...
	Dysarthria following cerebellar mutism secondary to resection of a fourth ventricle medulloblastoma: a case study.(risk factors): An article from: Journal of Medical Speech - Language Pathology by Yu-Tsai Wang (Author), Ray D. Kent (Author), Joseph R. Duffy (Author), Jack E. Thomas (Author), Geoffrey V. Fredericks (Author) This digital document is an article from Journal of Medical Speech - Language Pathology, published by Thomson Gale on June 1, 2006. The length of the article is 7188 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Dysarthria following cerebellar mutism secondary to resection of a fourth ventricle medulloblastoma: a case study.(risk factors) Author: Yu-Tsai Wang Publication: Journal of Medical Speech - Language Pathology (Magazine/Journal) Date: June 1, 2006 Publisher: Thomson Gale Volume: 14 Issue: 2 Page: 109(14) Distributed by Thomson...
	Medulloblastoma: An entry from Thomson Gale's Gale Encyclopedia of Cancer, 2nd ed. by Edward, D.O., M.P.H. Rosick (Author) Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of Cancer,” a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures.
	Medulloblastoma: Webster's Timeline History, 1949 - 2007 by Icon Group International (Author) Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Medulloblastoma," including when used in literature (e.g. all authors that might have Medulloblastoma in their name). As such, this book represents the largest compilation of timeline events associated with Medulloblastoma when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts,...
	21st Century Pediatric Cancer Sourcebook: Childhood Central Nervous System Embryonal Tumors - Medulloblastoma, Pineoblastoma, Pineal Parenchymal Tumors, PNET, Medulloepithelioma, Ependymoblastoma by Progressive Management Authoritative information and practical advice from the nation's cancer experts about childhood central nervous system embryonal tumors, which includes medulloblastomas, pineoblastomas, pineal parenchymal tumors, PNET, medulloepitheliomas, and ependymoblastomas. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive compilation gives empowered patients, families, caregivers, nurses, and physicians the information they need to understand the diagnosis and treatment of these diseases. Conveniently organized contents include: Diagnostic Evaluation * Predictors of Outcome * Cellular Classification * Staging * Treatment Option Overview - Risk Stratification for Medulloblastoma * Surgery * Radiation Therapy * Surveillance...
	Medulloblastoma - Pipeline Review, Q1 2011 by Global Markets Direct (Author) Medulloblastoma - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Medulloblastoma - Pipeline Review, Q1 2011', provides an overview of the Medulloblastoma therapeutic pipeline. This report provides information on the therapeutic development for Medulloblastoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Medulloblastoma. 'Medulloblastoma - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by...
	Clinical case study: a 4-year-old boy with posterior fossa syndrome after resection of a medulloblastoma.(Case study): An article from: Journal of Neuroscience Nursing by Diane Schretzman Mortimer (Author) This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on August 1, 2011. The length of the article is 3170 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Clinical case study: a 4-year-old boy with posterior fossa syndrome after resection of a medulloblastoma.(Case study) Author: Diane Schretzman Mortimer Publication: Journal of Neuroscience Nursing (Magazine/Journal) Date: August 1, 2011 Publisher: American Association of Neuroscience Nurses Volume: 43 Issue: 4 Page: 225(5) Article Type: Case...